MOH — authorised 30 September 1997
- Marketing authorisation holder: CEPHALON
- Status: likely_approved
MOH authorised Gabitril on 30 September 1997
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 30 September 1997.
CEPHALON holds the Israeli marketing authorisation.